Back to search

Article

Drug-Gene Network Signature Modeling Predicts Breast Cancer Patient Response to Neoadjuvant Chemotherapy

2025-03-18

Abstract excerpt

<title>Abstract</title> <p>Neoadjuvant chemotherapy (NAC) has been a staple treatment for breast cancer (BRCA) patients regardless of the tumor histological type. While this treatment can be effective on a population level, the pathologic complete response (pCR) rate post-NAC for individual patients varies widely throughout various clinical demographic groups and has not dramatically changed in practice. Improvin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c849e3a-2848-57a4-93ca-abd27785f15d
DOI
10.21203/rs.3.rs-6130021/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Drug-Gene Network Signature Modeling Predicts Breast Cancer Patient Response to Neoadjuvant ChemotherapyDOI 10.21203/rs.3.rs-6130021/v1
A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patientsSemantic proximity
A novel twelve-gene signature to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancerSemantic proximity
Relationship Between Gene Expression and Drug Response in Triple-Negative Breast Cancer: Leveraging Single-Cell RNA Sequencing and Machine Learning to Identify Biomarker ProfilesSemantic proximity
Integrated single-cell and bulk RNA sequencing analysis identifies the predictive signature for prognosis and neoadjuvant chemotherapy responses in breast cancerSemantic proximity
Identification of a 10-Gene Signature Model to Predict Efficacy of Neoadjuvant Therapy in Patients With HER2&nbsp;Positive Breast Cancer.Semantic proximity
A network model for patient-derived drug response in breast cancer integrating multi-omics datasetsSemantic proximity
Identification of A 10-Gene Signature To Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.Semantic proximity
Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Semantic proximity
RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancerSemantic proximity
Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patientsSemantic proximity
Integrated bioinformatics analysis reveals ISG15, IFIH1, OAS2, MX1, and CXCL10 as predictive biomarkers of neoadjuvant chemotherapy response in triple-negative breast cancerSemantic proximity
A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast CancerSemantic proximity
Select a neighboring publication to make it the new centre.